Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 8/20 | 0.46 |
| ▸ | CACNA1B | Q00975 | 5/20 | 0.45 |
| ▸ | CTSS | P25774 | 6/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | KLK7 | P49862 | 1/20 | 0.40 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24313584 | 1.00 | CYP1A2 (0.48) | CYP1A2CYP2C9CYP2C19HTTCYP2D6 | |
| SCHEMBL8349514 | 0.93 | CYP1A2 (0.48) | CYP1A2CYP2C9CYP2C19HTTCYP2D6 | |
| SCHEMBL7298384 | 0.93 | CYP1A2 (0.48) | CYP1A2CYP2C9CYP2C19HTTCYP2D6 | |
| SCHEMBL15166934 | 0.93 | CYP1A2 (0.48) | CYP1A2CYP2C9CYP2C19HTTCYP2D6 | |
| SCHEMBL25491886 | 0.90 | CYP1A2 (0.49) | CYP1A2CYP2C9CYP2C19HTTCYP2D6 | |
| SCHEMBL25492170 | 0.87 | CYP2D6 (0.46) | CYP1A2CYP2C9CYP2C19HTTCYP2D6 | |
| SCHEMBL25492261 | 0.87 | CYP1A2 (0.47) | CYP1A2CYP2C9CYP2C19HTTCYP2D6 | |
| SCHEMBL2018992 | 0.86 | CTSK (0.48) | CYP1A2CYP2C9CYP2C19HTTCYP2D6 | |
| SCHEMBL344762 | 0.86 | CTSK (0.48) | CYP1A2CYP2C9CYP2C19HTTCYP2D6 | |
| SCHEMBL15075041 | 0.86 | CYP2D6 (0.54) | CYP1A2CYP2C9CYP2C19HTTCYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8901353-B2 | Polyimide precursor, polyimide, and liquid crystal aligning agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-12-02 | — | — | US | disclosed |
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
| WO-2011115080-A1 | POLYAMIC ACID ESTER LIQUID CRYSTAL ALIGNMENT AGENT, AND LIQUID CRYSTAL ALIGNMENT FILM USING SAME | 日産化学工業株式会社 (JP) | 2011-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | PUF60, F13A1, F12 | CYP1A2 4533/4885CYP2C9 4610/4885CYP2C19 4688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.